Mammography Screening Market Outlook 2022: United States Opportunity and Demand Analysis, Market Forecast 2017 - 2022
-
Product Code:
RP-ID-10077098 -
Published Date:
24 Feb 2020 -
Region:
Global
-
Pages:
70 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-24
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
“Mammography Screening Market Outlook 2022: United States Opportunity and Demand Analysis, Market Forecast 2017-2022” provides a deep and thorough evaluation of the United States mammography screening market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.
Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. Additionally, the report includes assessment of breast cancer clinical trials and mammography reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States mammography screening market.
The report concludes with the profiles of major manufacturers of mammography system such as Hologic, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on parameters such as business overview and mammography marketed products.
Key Topics Covered in the Report
• United States Breast Cancer Cases (2010 - 2022)
• United States Breast Cancer Mammography Screening Population (2010 – 2022)
• United States Breast Cancer Death (2010 – 2017)
• Market Overview: United States Mammography Screening (2010 – 2022)
• Reimbursement Policies of the United States Breast Cancer Screening
• Breast Cancer Screening Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the United States Mammography Screening Market
• Key Manufacturers Analysis
Major Companies Covered in this Report:
• Hologic
• Siemen Healthineers
• Philips Healthcare
• GE Healthcare
• Toshiba Medical Systems Corporation
1. Executive Summary
2. Breast Cancer Facts
3. United States Breast Cancer Cases & Population (2010 – 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010 – 2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death
4. Market Overview: United States Mammography Screening (2010 – 2022)
5. Key Drivers and Inhibitors of the United States Mammography Screening Market
5.1 Market Drivers
5.2 Market Inhibitors
6. Reimbursement Policies of the United States Mammography Screening
7. Breast Cancer Screening Clinical Trail Insight by Phase, Company & Country
7.1 Year 2017
7.2 Year 2016
7.3 Year 2015
8. Key Manufacturers Analysis
8.1 Hologic
8.1.1 Business Overview
8.1.2 Mammography – Marketed Products
8.2 Siemens Healthineers
8.2.1 Business Overview
8.2.2 Mammography – Marketed Products
8.3 Philips Healthcare
8.3.1 Business Overview
8.3.2 Mammography – Marketed Products
8.4 Toshiba Medical Systems Corporation
8.4.1 Business Overview
8.4.2 Mammography – Marketed Products
8.5 GE Healthcare
8.5.1 Business Overview
8.5.2 Mammography – Marketed Products
2. Breast Cancer Facts
3. United States Breast Cancer Cases & Population (2010 – 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010 – 2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death
4. Market Overview: United States Mammography Screening (2010 – 2022)
5. Key Drivers and Inhibitors of the United States Mammography Screening Market
5.1 Market Drivers
5.2 Market Inhibitors
6. Reimbursement Policies of the United States Mammography Screening
7. Breast Cancer Screening Clinical Trail Insight by Phase, Company & Country
7.1 Year 2017
7.2 Year 2016
7.3 Year 2015
8. Key Manufacturers Analysis
8.1 Hologic
8.1.1 Business Overview
8.1.2 Mammography – Marketed Products
8.2 Siemens Healthineers
8.2.1 Business Overview
8.2.2 Mammography – Marketed Products
8.3 Philips Healthcare
8.3.1 Business Overview
8.3.2 Mammography – Marketed Products
8.4 Toshiba Medical Systems Corporation
8.4.1 Business Overview
8.4.2 Mammography – Marketed Products
8.5 GE Healthcare
8.5.1 Business Overview
8.5.2 Mammography – Marketed Products
